STAT Plus: Pharmalittle: Azar bars FDA from signing new rules; AstraZeneca reveals Covid-19 vaccine trial protocol
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Category: Pharma
STAT Plus: New drug combination extends survival with advanced kidney cancer. It’s poised to enter a competitive treatment market
Patients with advanced kidney cancer live longer when treated with a combination of drugs from…
STAT Plus: Pharmalittle: Roche says its drug helped Covid-19 patients; Trump expected to finalize drug importation plan
And so, another working week will soon draw to a close. Not a moment too…
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Nearly a dozen state treasurers are asking Gilead Sciences (GILD) to lower the price of…
.jpg)
STAT Plus: Pharmalittle: Biden-aligned group releases drug-pricing plan; U.S. to ship Covid-19 vaccines lickety-split
Rise and shine, everyone, another busy day is on the way. Most days are quite…
STAT Plus: The cost of Gilead’s HIV prevention pill thwarted widespread use, study finds
The escalating cost of the only HIV prevention pill may have been a key factor…
STAT Plus: Pharmalittle: Lilly drug helped Covid-19 patients; FDA confirms AstraZeneca vaccine trial is on hold
Top of the morning to you, and a fine one it is. Once again, a…
STAT Plus: Lawmakers demand drug makers stop threatening to end discounts for safety-net hospitals
Dozens of U.S. lawmakers sent sharply worded letters to the Trump administration and the pharmaceutical…
STAT Plus: Court rules New York can collect taxes from drug makers to address opioid crisis
A U.S. appeals court upheld a controversial New York state law to require drug makers…
STAT Plus: FDA warns Sprout for failing to mention risks in radio ad for Addyi
The Food and Drug Administration has admonished Sprout Pharmaceuticals for running a radio ad that…
STAT Plus: Pharmalittle: Gates is ‘dumbfounded’ by U.S. Covid-19 response; WHO urges countries to join COVAX
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT Plus: Pharmalittle: Gilead to pay $21 billion to buy Immunomedics; Trump releases executive order on drug pricing
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: A Pennsylvania lawmaker wants to tie prescription drug prices to what Canada pays
In the latest gambit by a state lawmaker to lower prescription drug costs, a Pennsylvania…
STAT Plus: Pharmalittle: NIH to test blood thinners against Covid-19; AbbVie employees feel pressured to return to work
And so, another working week will soon draw to a close. Not a moment too…
Novartis and Roche are fined $528 million for anti-competitive practices in France
France’s anti-trust regulator fined Roche (RHHBY) and Novartis (NVS) a combined $528 million for conspiring…
STAT Plus: Pharmalittle: AstraZeneca hopes for Covid-19 vaccine results by year-end; fewer Americans trust the CDC
Hello, everyone, and how are you today? We are just fine, thank you. A cool…
23andMe’s next challenge: ensuring its customers can get drugs developed with their data
23andme has long been known as a consumer genetic testing unicorn. But CEO Anne Wojcicki…
‘Everyone was left to guess what went wrong’: An open letter to AstraZeneca’s CEO on transparency
Dear Pascal Soirot, I’d like to talk to you about your priorities. Read the rest……
STAT Plus: U.S. Postal Service changes continue to slow down deliveries of mail-order prescriptions
When it comes to delivering prescription drugs to Americans, the U.S. Postal Service may as…
STAT Plus: Pharmalittle: AstraZeneca pauses its Covid-19 vaccine trial; FDA sticking with its vaccine approval guidelines
Rise and shine, everyone, another busy day is on the way. Our first clue is…
STAT Plus: Drug and device makers paid teaching hospitals $832 million in 2018, creating potential for conflicts of interest
Amid ongoing concern that drug and device makers may influence medical practice and research, a…
STAT Plus: Pharmalittle: Covid-19 vaccine makers pledge to prioritize safety and efficacy; is Operation Warp Speed working?
Good morning, everyone, and nice to see you again after a long holiday break on…
STAT Plus: Merck chronic cough drug shows mixed results in late-stage clinical trials, raising questions about its future
An experimental pill from Merck reduced the frequency of chronic coughing enough to achieve the…
Amid broad mistrust of FDA and Trump administration, drug companies seek to reassure public about Covid-19 vaccine safety
WASHINGTON — A group of nine leading pharmaceutical and biotechnology companies pledged on Tuesday to…
STAT Plus: ‘An unchartered situation for all of us’: From shipping containers to security concerns, a Covid-19 vaccine supply chain takes shape
For the past few months, Joachim Kuhn has scrambled to rework his factories and rapidly…
Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to
Talk about a rebuke. President Trump may want a Covid-19 vaccine to ship in time…
STAT Plus: A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents
A second U.S. government agency is now reviewing whether Moderna (MRNA) properly disclosed millions of…
STAT Plus: ‘The race is on’: China’s I-Mab gets boost from AbbVie to develop a new cancer immunotherapy
HONG KONG — In November 2014, a little less than six years ago, Chinese scientist…
STAT Plus: Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?
Good morning. Elizabeth Cooney here, taking the wheel from Ed Silverman today as we ponder…
STAT Plus: Pharmalittle: States asked to speed Covid-19 vaccine distribution sites; NIH panel contradicts FDA on plasma
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT Plus: Pharmalittle: U.S. won’t join WHO Covid-19 vaccine program; experts say a vaccine is possible this fall
Top of the morning to you, and a fine one it is. Despite the gray…
STAT Plus: FDA cites Mylan for ‘repeated failures’ at manufacturing plants in India
For the second time in less than a year, the Food and Drug Administration has…
STAT Plus: Congressional committee to subpoena AbbVie in drug pricing investigation
A Congressional committee plans to subpoena AbbVie (ABBV) for documents about pricing practices for two…
STAT Plus: Pharmalittle: Sanofi drug fails to tackle serious Covid-19 cases; EC agrees to fund WHO Covax program
Rise and shine, everyone, another busy day is on the way. Summertime may still be…
STAT Plus: Mylan launches a low-cost biosimilar insulin, but experts say many patients may not save on costs
Amid a national outcry over the cost of insulin, one of the largest generic companies…
STAT Plus: Coalition urges Justice Department to seek criminal charges against opioid executives
A coalition of advocacy groups and families is asking the Department of Justice to pursue…
STAT Plus: Pharmalittle: FDA is willing to fast-track a Covid-19 vaccine; most Americans worry politics drives vaccine approval process
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Most Americans believe the Covid-19 vaccine approval process is driven by politics, not science
Seventy-eight percent of Americans worry the Covid-19 vaccine approval process is being driven more by…
Moderna failed to disclose federal funding for vaccine patent applications, advocates say
An advocacy group has asked the Department of Defense to investigate what it called “an…
STAT Plus: Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering
Good morning, everyone. Damian Garde here, filling in for Ed Silverman in the waning hours…
STAT Plus: Employers are planning how to blunt the cost of pricey new specialty drugs
As the pharmaceutical industry develops increasingly expensive medicines – notably, those costing seven figures –…
STAT Plus: Pharmalittle: Trump launches a crusade against the FDA; Europe signs Covid-19 vaccine deal with AstraZeneca
Rise and shine, everyone, another busy day is on the way. The Pharmalot campus, for…
STAT Plus: Catalyst takes it fight over a rare disease drug to Canada, suing the country’s regulator
An unusual battle between two small companies over the market for a rare disease drug…
.jpg)
STAT Plus: Pharmalittle: Covid-19 vaccine makers push EU for liability protections; pharma plans counteroffer to Trump
Good morning, everyone, and how are you today? Another busy day is unfolding here on…
STAT Plus: U.S. authorities expected to file charges against Teva in generic price fixing probe
Federal prosecutors reportedly plan to charge Teva Pharmaceuticals (TEVA) of conspiring with other manufacturers of…
STAT Plus: Cardinal Health is accused of running a ‘rent-a-vet’ scheme to win government contracts
The largest association of independent nuclear pharmacies in the U.S. is accusing Cardinal Health (CAH),…
STAT Plus: Pharmalittle: Hahn apologizes for statistical blunder; Fauci warns of approving a Covid-19 vaccine too soon
Top of the morning to you, and a fine one it is. Blue skies and…
STAT Plus: Sun Pharma unit to pay $21 million for giving docs false instructions for an acne treatment
A unit of Sun Pharmaceuticals agreed to pay nearly $21 million to settle allegations of…
STAT Plus: Pharmacists say they tell patients about physical changes to pills, but consumers say that isn’t always the case
Most consumers say they aren’t notified of physical changes in their prescription pills, even though…
Amid pressure from scientists, NIH will study Gilead’s remdesivir-like compound against Covid-19
The National Institutes of Health plans to independently explore whether a Gilead Sciences (GILD) compound,…